How to use lytic bacteriophages in the treatment of biofilm-forming bacteria involved in prosthetic joint infections?

Dr. Mariagrazia Di Luca from the Charité – Universitätsmedizin Berlin Hospital, Berlin, Germany was invited to give a presentation during Florence Targeting Phage & Antibiotic Resistance Congress 2017. Her presentation will present the role of the lytic bacteriophages in the treatment of biofilm-forming bacteria involved in prosthetic joint infections.

According to Dr Di Luca, the infections involving medical implants represent a unique challenge due to the formation of biofilm in which bacteria are up to a thousand times more resistant to antibiotics than their planktonic counterparts. Lytic bacteriophages, when active against biofilms, represent a promising treatment, particularly against drug resistant bacteria. 

The present communication will focus on the anti-biofilm activity of both commercially available and newly isolated bacteriophages against bacterial strains relevant in the context of prosthetic joint infection.

For more information about Dr Di Luca, please click here.